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1. Current literature highlights
1.1 Thrombin inhibitors
Thrombin is a trypsin-like serine protease which plays a
crucial role in blood coagulation by cleaving soluble
fibrinogen into fibrin. Subsequent polymerisation of
fibrin stabilises the initially formed thrombozyte clots at
the site of blood vessel damage. Undesired activation of
the blood coagulation cascade can result in
cardiovascular disorders such as deep vein thrombosis,
myocardial infarction, unstable angina, pulmonary
embolism and ischaemic stroke. Thrombin has therefore
become an important target for the treatment of
thromboembolic diseases.
Approaches to thrombin inhibitors have centred around
the D-Phe-Pro-Arg motif that mimics the natural
substrate. D-Phe replaces the Phe residue in fibrinogen
which normally occupies the lipophilic D pocket. The
guanidine moiety of Arg which is also present in the
natural substrate forms a salt bridge with Asp189 at the
bottom of the specificity pocket of thrombin.
Interactions with Ser195 in the active centre of
thrombin were shown not to be essential for high
affinity to the enzyme. In an effort to optimise potency
and selectivity of thrombin inhibitors, a combinatorial
chemistry approach was undertaken [1].
A small library was synthesised on 4-nitrophenyl
carbonate Wang-resin (Novabiochem) in an attempt to
generate potent thrombin inhibitors. The library
compounds were evaluated in a chromogenic assay and
one of the most potent compounds found was (i) which
possesses a thrombin inhibition IC50 of 3.6 nM.
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1.2 Liver X receptor agonists
The increased incidence of cardiovascular disease
(CVD) in westernised nations has been linked to
increased dietary intake of cholesterol and saturated fats
and an increase in low-density lipoprotein (LDL)
particles. Accumulation of small, dense LDL particles
in the arterial wall leads to the formation of cholesterol
laden foam cells, which are the hallmark of coronary
atherosclerosis, and activation of the immune system.
Although cholesterol-lowering drugs such as statins
reduce the incidence of CVD in patients with high
circulating levels of LDL cholesterol (LDLc),
atherosclerosis also afflicts individuals with relatively
normal levels of LDLc. In contrast to LDL, the levels of
high-density lipoprotein (HDL) particles are inversely
related to the incidence of CVD. The protective role of
HDL may result from its role in mediating ‘reverse
cholesterol transport’ whereby cholesterol is transported
from peripheral cells back to the liver. Thus agents that
promote reverse cholesterol transport by raising
circulating levels of HDL could provide an alternative
therapeutic option for the prevention of atherosclerotic
CVD.
The liver X receptors, LXRa (NR1H3) and LXRß
(NR1H2) are oxysterol-activated transcripted factors
that belong to the nuclear hormone receptor
superfamily. It has been proposed that compound (ii) is
an endogenous ligand for LXRa in the liver. Upon
cholesterol feeding, the hepatic levels of (ii) are raised
in rats to levels consistent with its putative role as a
natural LXRa agonist.
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The identification of a novel chemical series of LXR
agonists through solid-phase parallel synthesis of
tertiary amines has recently been reported [2]. A library
of 1280 compounds was synthesised on Rink amide
solid phase resin, the design of which was based on the
GlaxoSmithKline high-throughput screening hit (iii).
The library compounds were screened for activity in the
cell-free ligand-sensing assay (LiSA) for human LXRα.
The LXRα LiSA measures the ligand-dependent
recruitment of a 24 amino acid fragment of the steroid
receptor coactivator 1 (SRC1) to the ligand-binding
domain of the receptor. One of the most potent
compounds isolated was (iv) which possessed an EC50
of 45 nM in the LXRα/SRC1 LiSA. This work has
provided a novel, potent lead for the development of
drugs to increase reverse cholesterol transport and
further work in this area is warranted.
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2. A summary of the papers in this month’s issue.
2.1 Solid-phase synthesis
Solid-phase cross metathesis of supported styrenyl ether
with styrene derivatives has produced stilbenoids in
high yields [3].
A novel synthesis of 2,3,5-trisubstituted 4H-
imidazolones on Merrifield resin has been reported [4].
A new approach for the synthesis of phosphine-
oxazoline peptide ligands by solid-phase methods has
been published [5].
2,6,9-Trisubstituted purines have been synthesised from
resin-bound 6-thiopurines using a traceless solid-phase
method [6].
Free radical addition of haloalkanes to polymer-bound
olefins has been used in the solid-phase synthesis of
pyrethroids [7].
Merrifield-supported o-cresol undergoes electrophilic
aromatic chlorination using SO2Cl2 resulting in
para/ortho ratios in excess of 50 [8].
A versatile method for the solid-phase synthesis of 3,5-
disubstituted oxazolidin-2-ones has been described [9].
The solid-phase synthesis of 2-substituted-3-(substituted
sulphanyl)-1,2,4-benzothiadiazine 1,1-dioxide has been
developed [10].
4,6-Dichloro-2-(methylthio)-5-nitropyrimidine has been
used as a building block for an efficient nine-step
synthesis of olomoucine. [11].
The solid-supported synthesis of functionalised 1,2,4-
triazin-6-ones from resin-bound amino acids and acid
chlorides has been described [12].
2.2 Solution-phase synthesis
Diverse 4-thiazolidinones have been assembled by
DCC-mediated three-component reactions of amines,
aldehydes and mercaptoacetic acid [13].
A method for the solution-phase synthesis of substituted
imidazoles from cyclic or acyclic 1,2-aminoalcohols has
been used to prepare libraries of fused imidazole-
azepines [14].
Soluble-polymer-supported synthesis of Biginelli
compounds has been used to prepare 3,4-
dihydropyrimidin-2(1H)-ones [15].
A method for the solid-phase synthesis of a-
sulphonylamino amides has been developed using an
Ugi-type 4-component condensation [16].
2.3 Library intermediates
Twenty-four bifunctional diketopiperazines with the
potential for incorporation into combinatorial libraries
have been synthesised [17].
2.4 Solid-supported reagents
Isonitriles have been successfully synthesised by the use
of microwave irradiation and solid-supported sulphonyl
chlorides [18].
Cis-constrained norstatine analogues have been
prepared using a trimethylsilyl azide-modified Passerini
three-component reaction [19].
A novel method for the synthesis of protected
guanidines relies on the use of polystyrene-supported
carbodiimide [20].
Manganese porphyrin catalysts have been supported on
Merrifield and Argogel resins and used for alkene
epoxidation [21].
A chiral polymer-supported sulphonamide has been
used to catalyse the enantioselective reduction of ß-keto
sulphones [22].
2.5 Novel resins, linkers and techniques
A new multidetachable linker has been used to prepare
libraries of sulphamates and phenols [23].
Cyclopentadienylmanganese tricarbonyl resins have
been used as potential olefin traceless supports [24].
Chiral enzyme inhibitors have been immobilized on
solid supports by amid-forming coupling and olefin
metathesis and used to for lipase inhibition studies [25].
2.6 Library applications
The use of the triterpenoid lupeol as a scaffold for the
solid-phase synthesis of libraries, tested for in vitro
antimalarial activity, has been described [26].
A combinatorial library of indinavir analogues has been
synthesised on solid support in order to find a
replacement for the aminoindanol moiety [27].
Benzofurans have been prepared on solid support and
investigated as selective estrogen receptor modulators
[28].
Two structural classes of dual a4ß1/a4ß7 integrin
antagonists have been investigated using solid-phase
parallel synthesis [29].
Parallel synthesis has been used to explore the SAR of
acyl dipeptide reversible caspase inhibitors [30]. A new
structural class has been optimised for activity against
caspases 1,3,6,7, and 8 [31].
A general solid-phase method has been developed to
prepare novel cyclic ketone inhibitors of the cysteine
protease cruzain [32].
The incorporation of acidic functionality into a
combinatorial library-derived CCR5 antagonist has
resulted in compounds with enhanced anti-HIV-1
activity [33].
Parallel solution and solid-phase methods have been
used to synthesise spirohydantoin derivatives as
neurokinin-1 receptor ligands [34].
Parallel synthesis of 31 sulphonamides has led to the
discovery of a potent antimalarial compound [35].
Screening of a solid-phase peptide library has delivered
a dsDNA binding molecule with preference for
pyrimidine sequences [36].
A purine-scaffold based library has been employed in
the discovery of a novel class of HSP90 molecular
chaperone inhibitor [37].
The synthesis of a P1 arginine peptide combinatorial
library has been used to determine substrate specificity
of serine peptidases [38].
A focused library of di- and tri-peptidomimetics have
been designed and synthesised as possible ACE
inhibitors [39].
A structurally diverse carbohybrid library has been used
to identify novel inhibitors of fibroblast growth factor
(FGF-2) binding to heparin [40].
An efficient method for the solid-phase synthesis of
tripeptide-bearing glycopeptide antibiotics has been
used to generate a combinatorial library of derivatives
of chloroorienticin B [41].
Parallel solution- and solid-phase synthesis of
spiropyrrolo-pyrrole libraries has been used in the
search for novel neurokinin receptor ligands [42].
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